Disclosure Of Entity's Operating Segments [Text Block]

Sopharma Trading AD - Filing #6022492

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Depreciation and amortisation expense	—	—	—	—	—	—	28,554,000.000 BGN	—	—	—	—	20,040,000.000 BGN	—	—	—	—
Tax expense (income)	—	—	—	—	—	—	1,387,000.000 BGN	—	—	—	—	2,446,000.000 BGN	—	—	—	—
Profit (loss) before tax	—	—	—	—	—	—	9,437,000.000 BGN	—	—	—	—	13,922,000.000 BGN	—	—	—	—
Profit (loss)	—	- BGN	- BGN	- BGN	- BGN	- BGN	8,050,000.000 BGN	8,050,000.000 BGN	11,476,000.000 BGN	—	- BGN	11,476,000.000 BGN	- BGN	- BGN	- BGN	- BGN
Assets	582,859,000.000 BGN	—	—	—	—	—	—	—	—	616,529,000.000 BGN	—	—	—	—	—	—
Liabilities	497,959,000.000 BGN	—	—	—	—	—	—	—	—	539,591,000.000 BGN	—	—	—	—	—	—
Cash flows from (used in) operating activities	—	—	—	—	—	—	172,859,000.000 BGN	—	—	—	—	217,090,000.000 BGN	—	—	—	—
Cash flows from (used in) investing activities	—	—	—	—	—	—	14,325,000.000 BGN	—	—	—	—	9,988,000.000 BGN	—	—	—	—
Cash flows from (used in) financing activities	—	—	—	—	—	—	191,752,000.000 BGN	—	—	—	—	226,830,000.000 BGN	—	—	—	—